Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011483

Principal Accounting Officer sold 152 shares at $76.45 ($11,620)

  • Principal Accounting Officer gave up 278 shares (to pay taxes)
  • Principal Accounting Officer acquired 790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Alenson Carman Principal Accounting Officer 2018-09-28 Sale −152 $76.45 $11,620 0 D: show line 1 in the form
Alenson Carman Principal Accounting Officer 2019-02-16 Option exercise +790 790 D: show line 2 in the form
Alenson Carman Principal Accounting Officer 2019-02-19 Shares withheld for taxes −278 $58.03 $16,132 512 D: show line 3 in the form
Open-market sales · 152 sh · avg $76.45 · $11,620

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Alenson Carman Principal Accounting Officer 2019-02-16 Option exercise · Restricted stock units −790 1,580 D: show line 4 in the form
Loading xslF345X03/doc4.xml…